
Invacare Corporation IVC
Quartalsbericht 2023-Q1
hinzugefügt 15.05.2023
Invacare Corporation EV/EBITDA 2011-2026 | IVC
EV/EBITDA Jährlich Invacare Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.89 | 15.3 | 15.6 | 238 | -60.3 | -79.1 | 38.9 | -121 | 58.2 | 10.6 | 6.9 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 238 | -121 | 11.4 |
EV/EBITDA anderer Aktien in der Medizinische Geräte
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
-0.204 | - | - | $ 17.2 B | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
-8.6 | $ 21.04 | 0.86 % | $ 3.01 B | ||
|
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Apyx Medical Corporation
APYX
|
-29.2 | $ 3.5 | 1.74 % | $ 121 M | ||
|
Cognyte Software Ltd.
CGNT
|
23 | $ 9.4 | 1.08 % | $ 675 M | ||
|
Boston Scientific Corporation
BSX
|
25.2 | $ 95.35 | -0.69 % | $ 140 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
34.5 | $ 302.99 | -0.5 % | $ 8.55 B | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
Cutera
CUTR
|
236 | - | -10.19 % | $ 1.99 M | ||
|
Bruker Corporation
BRKR
|
-2.13 | $ 47.11 | -0.84 % | $ 7.02 K | ||
|
Electromed
ELMD
|
26.4 | $ 29.12 | 1.01 % | $ 246 M | ||
|
Abbott Laboratories
ABT
|
20.3 | $ 125.29 | -0.39 % | $ 218 B | ||
|
EDAP TMS S.A.
EDAP
|
730 | $ 3.29 | 2.49 % | $ 123 M | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
IRadimed Corporation
IRMD
|
46 | $ 97.28 | -0.5 % | $ 1.23 B | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Zynex
ZYXI
|
11.6 | - | - | $ 21.1 M | ||
|
InMode Ltd.
INMD
|
23.3 | $ 14.69 | -1.01 % | $ 1.17 B | ||
|
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | ||
|
Align Technology
ALGN
|
48.9 | $ 156.15 | -1.26 % | $ 11.7 B | ||
|
Accuray Incorporated
ARAY
|
19.9 | $ 0.82 | 2.64 % | $ 84.3 M | ||
|
LivaNova PLC
LIVN
|
215 | $ 61.53 | -1.2 % | $ 3.34 B | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
LENSAR
LNSR
|
-1.48 | $ 11.63 | - | $ 134 M | ||
|
ClearPoint Neuro
CLPT
|
-9.73 | $ 13.68 | 0.81 % | $ 370 M | ||
|
FONAR Corporation
FONR
|
-33.4 | $ 18.56 | -0.22 % | $ 122 M | ||
|
AxoGen
AXGN
|
-19.1 | $ 32.73 | - | $ 1.45 B | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.14 | -0.87 % | $ 18.4 M | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 40.6 | -1.31 % | $ 1.25 B | ||
|
OrthoPediatrics Corp.
KIDS
|
-165 | $ 17.76 | -1.11 % | $ 410 M | ||
|
Globus Medical
GMED
|
27.6 | $ 87.31 | -0.68 % | $ 11.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
29.6 | $ 12.42 | -2.05 % | $ 956 M | ||
|
Myomo
MYO
|
-2.96 | $ 0.91 | -1.58 % | $ 6.42 M |